Martina Winkler1, Johanna Schuchard1,2, Ines Stölting1, Florian M Vogt3, Jörg Barkhausen3, Christoph Thorns4, Michael Bader5,6,7,8, Walter Raasch1,2,9. 1. Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany. 2. DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Lübeck, Germany. 3. Department for Radiology and Nuclear Medicine, University of Lübeck, Lübeck, Germany. 4. Department of Pathology, University Clinic Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. 5. Max-Delbrück-Center for Molecular Medicine (MDC), Berlin, Germany. 6. DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany. 7. Center for Structural and Cell Biology in Medicine, Institute for Biology, University of Lübeck, Lübeck, Germany. 8. Charité - University Medicine Berlin, Berlin, Germany. 9. CBBM (Center of Brain, Behavior and Metabolism), Lübeck, Germany.
Abstract
BACKGROUND AND PURPOSE: Reduced weight gain after treatment with AT1 receptor antagonists may involve a brain-related mechanism. Here, we investigated the role of the brain renin-angiotensin system on weight regulation and food behaviour, with or without additional treatment with telmisartan. METHODS: Transgenic rats with a brain-specific deficiency in angiotensinogen (TGR(ASrAOGEN)) and the corresponding wild-type, Sprague Dawley (SD) rats were fed (3 months) with a high-calorie cafeteria diet (CD) or standard chow. SD and TGR(ASrAOGEN) rats on the CD diet were also treated with telmisartan (8 mg·kg(-1) ·d(-1) , 3 months). RESULTS: Compared with SD rats, TGR(ASrAOGEN) rats (i) had lower weights during chow feeding, (ii) did not become obese during CD feeding, (iii) had normal baseline leptin plasma concentrations independent of the feeding regimen, whereas plasma leptin of SD rats was increased due to CD, (iv) showed a reduced energy intake, (v) had a higher, strain-dependent energy expenditure, which is additionally enhanced during CD feeding, (vi) had enhanced mRNA levels of pro-opiomelanocortin and (vii) showed improved glucose control. Weight gain and energy intake in rats fed the CD diet were markedly reduced by telmisartan in SD rats but only to a minor extent in TGR(ASrAOGEN) rats. CONCLUSIONS: The brain renin-angiotensin system affects body weight regulation, feeding behaviour and metabolic disorders. When angiotensin II levels are low in brain, rats are protected from developing diet-induced obesity and obesity-related metabolic impairments. We further suggest that telmisartan at least partly lowers body weight via a CNS-driven mechanism.
BACKGROUND AND PURPOSE: Reduced weight gain after treatment with AT1 receptor antagonists may involve a brain-related mechanism. Here, we investigated the role of the brain renin-angiotensin system on weight regulation and food behaviour, with or without additional treatment with telmisartan. METHODS: Transgenic rats with a brain-specific deficiency in angiotensinogen (TGR(ASrAOGEN)) and the corresponding wild-type, Sprague Dawley (SD) rats were fed (3 months) with a high-calorie cafeteria diet (CD) or standard chow. SD and TGR(ASrAOGEN) rats on the CD diet were also treated with telmisartan (8 mg·kg(-1) ·d(-1) , 3 months). RESULTS: Compared with SD rats, TGR(ASrAOGEN) rats (i) had lower weights during chow feeding, (ii) did not become obese during CD feeding, (iii) had normal baseline leptin plasma concentrations independent of the feeding regimen, whereas plasma leptin of SD rats was increased due to CD, (iv) showed a reduced energy intake, (v) had a higher, strain-dependent energy expenditure, which is additionally enhanced during CD feeding, (vi) had enhanced mRNA levels of pro-opiomelanocortin and (vii) showed improved glucose control. Weight gain and energy intake in rats fed the CD diet were markedly reduced by telmisartan in SD rats but only to a minor extent in TGR(ASrAOGEN) rats. CONCLUSIONS: The brain renin-angiotensin system affects body weight regulation, feeding behaviour and metabolic disorders. When angiotensin II levels are low in brain, rats are protected from developing diet-induced obesity and obesity-related metabolic impairments. We further suggest that telmisartan at least partly lowers body weight via a CNS-driven mechanism.
Authors: Annette D de Kloet; Eric G Krause; Karen A Scott; Michelle T Foster; James P Herman; Randall R Sakai; Randy J Seeley; Stephen C Woods Journal: Am J Physiol Endocrinol Metab Date: 2011-08-23 Impact factor: 4.310
Authors: F Massiéra; M Bloch-Faure; D Ceiler; K Murakami; A Fukamizu; J M Gasc; A Quignard-Boulange; R Negrel; G Ailhaud; J Seydoux; P Meneton; M Teboul Journal: FASEB J Date: 2001-10-15 Impact factor: 5.191
Authors: Hung Hsuchou; Yi He; Abba J Kastin; Hong Tu; Emily N Markadakis; Richard C Rogers; Paul B Fossier; Weihong Pan Journal: Brain Date: 2009-03-17 Impact factor: 13.501
Authors: Kristin E Claflin; Jeremy A Sandgren; Allyn M Lambertz; Benjamin J Weidemann; Nicole K Littlejohn; Colin M L Burnett; Nicole A Pearson; Donald A Morgan; Katherine N Gibson-Corley; Kamal Rahmouni; Justin L Grobe Journal: J Clin Invest Date: 2017-03-06 Impact factor: 14.808
Authors: Martina Winkler; Johanna Schuchard; Ines Stölting; Florian M Vogt; Jörg Barkhausen; Christoph Thorns; Michael Bader; Walter Raasch Journal: Br J Pharmacol Date: 2016-03-27 Impact factor: 8.739
Authors: Ruben Rodriguez; Jacqueline N Minas; Jose Pablo Vazquez-Medina; Daisuke Nakano; David G Parkes; Akira Nishiyama; Rudy M Ortiz Journal: J Endocrinol Date: 2018-04-11 Impact factor: 4.286
Authors: Zachary C Ahart; Laura E Martin; Bailey R Kemp; Debarghya Dutta Banik; Stefan G E Roberts; Ann-Marie Torregrossa; Kathryn F Medler Journal: Obesity (Silver Spring) Date: 2019-12-31 Impact factor: 5.002